194 related articles for article (PubMed ID: 16234061)
1. Molecular basis of hepatitis C virus-associated hepatocarcinogenesis: lessons from animal model studies.
Koike K
Clin Gastroenterol Hepatol; 2005 Oct; 3(10 Suppl 2):S132-5. PubMed ID: 16234061
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis C virus contributes to hepatocarcinogenesis by modulating metabolic and intracellular signaling pathways.
Koike K
J Gastroenterol Hepatol; 2007 Jun; 22 Suppl 1():S108-11. PubMed ID: 17567457
[TBL] [Abstract][Full Text] [Related]
3. Molecular mechanism of viral hepatocarcinogenesis.
Koike K; Tsutsumi T; Fujie H; Shintani Y; Kyoji M
Oncology; 2002; 62 Suppl 1():29-37. PubMed ID: 11868782
[TBL] [Abstract][Full Text] [Related]
4. Role of hepatitis C virus in the development of hepatocellular carcinoma: transgenic approach to viral hepatocarcinogenesis.
Koike K; Moriya K; Kimura S
J Gastroenterol Hepatol; 2002 Apr; 17(4):394-400. PubMed ID: 11982718
[TBL] [Abstract][Full Text] [Related]
5. The oncogenic role of hepatitis C virus.
Koike K
Recent Results Cancer Res; 2014; 193():97-111. PubMed ID: 24008295
[TBL] [Abstract][Full Text] [Related]
6. Pathogenesis of HCV-associated HCC: Dual-pass carcinogenesis through activation of oxidative stress and intracellular signaling.
Koike K
Hepatol Res; 2007 Sep; 37 Suppl 2():S115-20. PubMed ID: 17877471
[TBL] [Abstract][Full Text] [Related]
7. [HCV core gene transgenic mouse as a model for viral hepatocarcinogenesis].
Koike K
Nihon Rinsho; 2001 Jul; 59(7):1265-70. PubMed ID: 11494535
[TBL] [Abstract][Full Text] [Related]
8. Molecular basis for the synergy between alcohol and hepatitis C virus in hepatocarcinogenesis.
Koike K; Tsutsumi T; Miyoshi H; Shinzawa S; Shintani Y; Fujie H; Yotsuyanagi H; Moriya K
J Gastroenterol Hepatol; 2008 Mar; 23 Suppl 1():S87-91. PubMed ID: 18336672
[TBL] [Abstract][Full Text] [Related]
9. Hepatocarcinogenesis in hepatitis C: HCV shrewdly exacerbates oxidative stress by modulating both production and scavenging of reactive oxygen species.
Fujinaga H; Tsutsumi T; Yotsuyanagi H; Moriya K; Koike K
Oncology; 2011; 81 Suppl 1():11-7. PubMed ID: 22212930
[TBL] [Abstract][Full Text] [Related]
10. Close association between high serum alanine aminotransferase levels and multicentric hepatocarcinogenesis in patients with hepatitis C virus-associated cirrhosis.
Tarao K; Rino Y; Ohkawa S; Tamai S; Miyakawa K; Takakura H; Endo O; Yoshitsugu M; Watanabe N; Matsuzaki S
Cancer; 2002 Mar; 94(6):1787-95. PubMed ID: 11920542
[TBL] [Abstract][Full Text] [Related]
11. Hepatocarcinogenesis in hepatitis viral infection: lessons from transgenic mouse studies.
Koike K
J Gastroenterol; 2002; 37 Suppl 13():55-64. PubMed ID: 12109667
[TBL] [Abstract][Full Text] [Related]
12. The Oncogenic Role of Hepatitis C Virus.
Koike K; Tsutsumi T
Recent Results Cancer Res; 2021; 217():91-105. PubMed ID: 33200363
[TBL] [Abstract][Full Text] [Related]
13. Ursodiol use is possibly associated with lower incidence of hepatocellular carcinoma in hepatitis C virus-associated liver cirrhosis.
Tarao K; Fujiyama S; Ohkawa S; Miyakawa K; Tamai S; Hirokawa S; Masaki T; Tanaka K
Cancer Epidemiol Biomarkers Prev; 2005 Jan; 14(1):164-9. PubMed ID: 15668491
[TBL] [Abstract][Full Text] [Related]
14. Promyelocytic leukemia protein deficiency leads to spontaneous formation of liver tumors in hepatitis C virus transgenic mice.
Straub K; Husen P; Baba HA; Trippler M; Wedemeyer H; Herzer K
Cancer Med; 2019 Jul; 8(8):3793-3802. PubMed ID: 31144474
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical detection of hcv in cirrhosis, dysplastic nodules, and hepatocellular carcinomas with parallel-tissue quantitative RT-PCR.
Rullier A; Trimoulet P; Urbaniak R; Winnock M; Zauli D; Ballardini G; Rosenbaum J; Balabaud C; Bioulac-Sage P; Le Bail B
Mod Pathol; 2001 May; 14(5):496-505. PubMed ID: 11353061
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis C virus and its roles in cell proliferation.
Shimotohno K; Watashi K; Tsuchihara K; Fukuda K; Marusawa H; Hijikata M
J Gastroenterol; 2002; 37 Suppl 13():50-4. PubMed ID: 12109666
[TBL] [Abstract][Full Text] [Related]
17. Mitochondrial damage and iron metabolic dysregulation in hepatitis C virus infection.
Hino K; Nishina S; Sasaki K; Hara Y
Free Radic Biol Med; 2019 Mar; 133():193-199. PubMed ID: 30268888
[TBL] [Abstract][Full Text] [Related]
18. Role of Oxidative Stress in Hepatitis C Virus Induced Hepatocellular Carcinoma.
Fu N; Yao H; Nan Y; Qiao L
Curr Cancer Drug Targets; 2017; 17(6):498-504. PubMed ID: 27677955
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis C virus infection and risk of hepatocellular carcinoma among Japanese: possible role of type 1b (II) infection.
Tanaka K; Ikematsu H; Hirohata T; Kashiwagi S
J Natl Cancer Inst; 1996 Jun; 88(11):742-6. PubMed ID: 8637028
[TBL] [Abstract][Full Text] [Related]
20. Polymorphisms in the hepatitis C virus core and its association with development of hepatocellular carcinoma.
Sedeno-Monge V; Vallejo-Ruiz V; Sosa-Jurado F; Santos-Lopez G
J Biosci; 2017 Sep; 42(3):509-521. PubMed ID: 29358564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]